- Q1 2024 Panbela Therapeutics Inc Earnings Call TranscriptMay 15, 2024$0.4 (-9.25%)Earnings
- Q4 2023 Panbela Therapeutics Inc Earnings Call TranscriptMar 26, 2024$0.64Earnings
- Q3 2023 Panbela Therapeutics Inc Earnings Call TranscriptNov 09, 2023$11.64 (-13.13%)Earnings
- Panbela Therapeutics Inc at LD Micro Main Event XVI Conference TranscriptOct 04, 2023
- Q2 2023 Panbela Therapeutics Inc Earnings Call TranscriptAug 10, 2023$33.8 (-2.31%)Earnings
- Panbela Therapeutics Inc Annual Shareholders Meeting TranscriptMay 25, 2023
- Q1 2023 Panbela Therapeutics Inc Earnings Call TranscriptMay 04, 2023$270 (-7.27%)Earnings
- Q4 2022 Panbela Therapeutics Inc Earnings Call TranscriptMar 16, 2023$396 (-0.74%)Earnings
- Panbela Therapeutics Inc Extraordinary Shareholders Meeting TranscriptNov 29, 2022
- Q3 2022 Panbela Therapeutics Inc Earnings Call TranscriptNov 10, 2022$2659.2 (+0.64%)Earnings
- Q2 2022 Panbela Therapeutics Inc Earnings Call TranscriptAug 15, 2022$28559.98 (-7.71%)Earnings
- Q1 2022 Panbela Therapeutics Inc Earnings Call TranscriptMay 12, 2022$38563.17 (-0.20%)Earnings
- Q3 2021 Panbela Therapeutics Inc Earnings Call TranscriptNov 10, 2021$48479.96 (-3.35%)Earnings
- Q2 2021 Panbela Therapeutics Inc Earnings Call TranscriptAug 11, 2021$57599.95 (-2.04%)Earnings
- Q1 2021 Panbela Therapeutics Inc Earnings Call TranscriptMay 12, 2021$95999.92 (-3.85%)Earnings
Q4 2022 Panbela Therapeutics Inc Earnings Call Transcript
Good day, everyone, and welcome to the Panbela Therapeutics' fourth-quarter 2022 earnings call. (Operator Instructions) It is now my pleasure to turn the floor over to your host, James Carbonara. Sir, the floor is yours.
Thank you, and once again, welcome to Panbela's fourth-quarter 2022 earnings call. With me on the call are Jennifer Simpson, Chief Executive Officer; and Sue Horvath, Chief Financial Officer.
Before I turn the call over to Dr. Simpson, please note that statements made on this call that are not historical facts may be forward-looking statements. Significant risks and uncertainties that could cause actual results to differ from those expressed or implied in the forward-looking statements are detailed in the company's annual report on Form 10-K and supplemented by the subsequently filed quarterly reports on Form 10-Q, as well as in other reports that the company files from time to time with the SEC.
Any forward-looking statements made on this call are made only as of today's date, and the company
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)